Author:
Vidal R.,Diaz A.,Pazos A.,Castro E.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F (2005) Strategies for producing faster acting antidepressants. Drug Discov Today 10:578–585. doi: 10.1016/S1359-6446(05)03398-2
2. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1–12. doi: 10.1677/joe.0.1600001
3. Artaiz I, Zazpe A, Innerarity A, Del Olmo E, Diaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A (2005) Preclinical pharmacology of F98214-TA, a novel potent serotonin and noradrenaline uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology (Berl) 182:400–413. doi: 10.1007/s00213-005-0087-3
4. Auerbach SB, Hjorth S (1995) Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn Schmiedeberg´s Arch Pharmacol 352:597–606. doi: 10.1007/BF00171317
5. Barden N, Reul JM, Holsboer F (1995) Do antidepressants stabilize mood through actions on the hypothalamic–pituitary–adrenocortical system? Trends Neurosci 18:6–11. doi: 10.1016/0166-2236(95)93942-Q
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献